MDM4 and melanoma: Hence, we experimented with melanoma A375 cells, and our results showed that treatment with MMRi62 for 24 h induced MDM4 downregulation in a concentration-dependent manner; furthermore, we observed that this activity could be rescued by using a 1 μM bortezomib treatment for 16 h before cell harvest (Figure 3D).